Hmg-coa Reductase Immune-mediated Necrotizing Myopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-24
Clinical Trial Update: The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy [Phase 2]
Phase 2 exploratory trial investigating intravenous immunoglobulin (IVIG) for anti-HMGCR immune-mediated necrotizing myopathy; currently rec…